| 000 | 00982 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515005845.0 | ||
| 264 | 0 | _c20060105 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDutour, A | |
| 245 | 0 | 0 |
_aTumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a3799-807 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aRigaud, M | |
| 773 | 0 |
_tAnticancer research _gvol. 25 _gno. 6B _gp. 3799-807 |
|
| 999 |
_c15932238 _d15932238 |
||